These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8132737)

  • 1. 1,1'-Ethylidenebis(tryptophan) (Peak E) induces functional activation of human eosinophils and interleukin 5 production from T lymphocytes: association of eosinophilia-myalgia syndrome with a L-tryptophan contaminant.
    Yamaoka KA; Miyasaka N; Inuo G; Saito I; Kolb JP; Fujita K; Kashiwazaki S
    J Clin Immunol; 1994 Jan; 14(1):50-60. PubMed ID: 8132737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of L-tryptophan products on function of human eosinophils: investigation of the causal mechanisms of eosinophilia myalgia syndrome associated with L-tryptophan products.
    Saito H; Miyamoto T
    Int Arch Allergy Immunol; 1996; 111 Suppl 1():37-42. PubMed ID: 8906111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-tryptophan contaminant 'peak E' induces the release of IL-5 and IL-10 by peripheral blood mononuclear cells from patients with functional somatic syndromes.
    Barth H; Klein R; Berg PA
    Clin Exp Immunol; 2001 Nov; 126(2):187-92. PubMed ID: 11703359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cause and pathogenesis of the eosinophilia-myalgia syndrome.
    Varga J; Uitto J; Jimenez SA
    Ann Intern Med; 1992 Jan; 116(2):140-7. PubMed ID: 1727618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophil-active cytokine from mononuclear cells cultured with L-tryptophan products: an unexpected consequence of endotoxin contamination.
    Kita H; Mayeno AN; Weyand CM; Goronzy JJ; Weiler DA; Lundy SK; Abrams JS; Gleich GJ
    J Allergy Clin Immunol; 1995 Jun; 95(6):1261-7. PubMed ID: 7797795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophilic major basic protein and interleukin-5 in eosinophilic myositis.
    Murata K; Sugie K; Takamure M; Fujimoto T; Ueno S
    Eur J Neurol; 2003 Jan; 10(1):35-8. PubMed ID: 12534990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal anti-interleukin-5 treatment suppresses eosinophil but not T-cell functions.
    Büttner C; Lun A; Splettstoesser T; Kunkel G; Renz H
    Eur Respir J; 2003 May; 21(5):799-803. PubMed ID: 12765424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of interleukin-5 by activated eosinophils in patients with eosinophilic heart diseases.
    Desreumaux P; Janin A; Dubucquoi S; Copin MC; Torpier G; Capron A; Capron M; Prin L
    Blood; 1993 Sep; 82(5):1553-60. PubMed ID: 8364205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophils express a functional receptor for interferon alpha: inhibitory role of interferon alpha on the release of mediators.
    Aldebert D; Lamkhioued B; Desaint C; Gounni AS; Goldman M; Capron A; Prin L; Capron M
    Blood; 1996 Mar; 87(6):2354-60. PubMed ID: 8630398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A decomposition product of a contaminant implicated in L-tryptophan eosinophilia myalgia syndrome affects spinal cord neuronal cell death and survival through stereospecific, maturation and partly interleukin-1-dependent mechanisms.
    Brenneman DE; Page SW; Schultzberg M; Thomas FS; Zelazowski P; Burnet P; Avidor R; Sternberg EM
    J Pharmacol Exp Ther; 1993 Aug; 266(2):1029-35. PubMed ID: 8355179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced collagen synthesis and transcription by peak E, a contaminant of L-tryptophan preparations associated with the eosinophilia myalgia syndrome epidemic.
    Takagi H; Ochoa MS; Zhou L; Helfman T; Murata H; Falanga V
    J Clin Invest; 1995 Nov; 96(5):2120-5. PubMed ID: 7593596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils.
    Kita H; Abu-Ghazaleh RI; Sur S; Gleich GJ
    J Immunol; 1995 May; 154(9):4749-58. PubMed ID: 7722326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of butyric acid on induction of differentiation into eosinophil-like cells in human eosinophilic leukemia cells, EoL-1 cell line: possible role of granulocyte-macrophage colony-stimulating factor as an autocrine differentiating factor.
    Saito H; Hayakawa T; Mita H; Akiyama K; Shida T
    Int Arch Allergy Immunol; 1993; 100(3):240-7. PubMed ID: 8453311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukotriene B4 induces interleukin 5 generation from human T lymphocytes.
    Yamaoka KA; Kolb JP
    Eur J Immunol; 1993 Oct; 23(10):2392-8. PubMed ID: 8405039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of a human eosinophilic leukemic cell line, EoL-1: characterization by the expression of cytokine receptors, adhesion molecules, CD95 and eosinophilic cationic protein (ECP).
    Wong CK; Ho CY; Lam CW; Zhang JP; Hjelm NM
    Immunol Lett; 1999 Jun; 68(2-3):317-23. PubMed ID: 10424438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypodense eosinophils and interleukin 5 activity in the blood of patients with the eosinophilia-myalgia syndrome.
    Owen WF; Petersen J; Sheff DM; Folkerth RD; Anderson RJ; Corson JM; Sheffer AL; Austen KF
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8647-51. PubMed ID: 2236076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EBT, a tryptophan contaminant associated with eosinophilia myalgia syndrome, is incorporated into proteins during translation as an amino acid analog.
    Buss WC; Stepanek J; Bankhurst AD; Mayeno AN; Pastuszyn A; Peabody D
    Autoimmunity; 1996; 25(1):33-45. PubMed ID: 9161698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-2 primes eosinophil degranulation in hypereosinophilia and Wells' syndrome.
    Simon HU; Plötz S; Simon D; Seitzer U; Braathen LR; Menz G; Straumann A; Dummer R; Levi-Schaffer F
    Eur J Immunol; 2003 Apr; 33(4):834-9. PubMed ID: 12672048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-5 messenger RNA expression in peripheral blood CD4+ cells in asthma.
    Lai CK; Ho AS; Chan CH; Tang J; Leung JC; Lai KN
    J Allergy Clin Immunol; 1996 Jun; 97(6):1320-8. PubMed ID: 8648029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wells' syndrome (eosinophilic cellulitis): correlation between clinical activity, eosinophil levels, eosinophil cation protein and interleukin-5.
    España A; Sanz ML; Sola J; Gil P
    Br J Dermatol; 1999 Jan; 140(1):127-30. PubMed ID: 10215782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.